Skip to content

Debora Copa

5 papers in the library · 36 citations · publishing 2024-2026

Papers

Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.

J Affect Disord February 27, 2024 Debora Copa, David Erritzøe, Bruna Giribaldi et al. 31 citations

Brain scans taken before psilocybin therapy for depression can help predict who will benefit most. In a study of patients with treatment-resistant depression, patterns of functional connectivity in resting-state fMRI scans at baseline were associated with the degree of symptom improvement after psilocybin treatment. Specific neural signatures in the brain's default mode network and frontoparietal network showed predictive value for treatment response. These findings suggest that pre-treatment brain imaging may eventually help tailor psilocybin therapy to individuals most likely to respond.

Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine

Journal of Cognitive Neuroscience December 30, 2025 Evan Lewis-Healey, Carla Pallavicini, Federico Cavanna et al. 4 citations

The psychedelic drug DMT rapidly reorganizes conscious experience and brain activity, but the link between brain dynamics and subjective effects remains unclear. In a blinded, dose-dependent study, 19 participants received 20 mg or 40 mg of DMT. The higher dose produced more intense visual hallucinations and emotional experiences. Electroencephalography data showed that alpha power and permutation entropy best tracked moment-to-moment changes in subjective experience, while Lempel-Ziv complexity—previously thought to be a strong correlate—showed the weakest association. The findings indicate that the relationship between neural complexity and psychedelic phenomenology is less straightforward than hypothesized.

Time-resolved neural and experience dynamics of medium- and high-dose DMT

bioRxiv Preprint Server December 19, 2024 Evan Lewis-Healey, Carla Pallavicini, Federico Cavanna et al. 1 citation preprint

A dose of the fast-acting psychedelic DMT rapidly reorganizes conscious experience and brain dynamics, but the link between neural complexity and subjective effects is weaker than previously thought. Nineteen participants received 20 mg or 40 mg of DMT in two sessions. The higher dose produced more extreme visual hallucinations and emotionally intense experiences. Contrary to earlier claims, Lempel-Ziv complexity—a measure of neural signal diversity—was the least strongly associated neural marker of the psychedelic state. The findings suggest the relationship between neural complexity and phenomenology during psychedelic experiences is less clear than originally hypothesized.

Multimodal autonomic arousal tracks dose-dependent affective dynamics during the acute effects of DMT

bioRxiv May 4, 2026 Tomás Ariel D’amelio, Tomás Gil Garbagnoli, Jerónimo Rodríguez Cuello et al.

Inhalation of DMT, a serotonergic psychedelic, produces a brief surge in sympathetic nervous system activity—heart rate, skin conductance, and respiration—that closely tracks the intensity of the emotional experience. Nineteen participants received 20 or 40 mg of DMT under a semi-naturalistic blinded design. Higher doses caused heart rate and breathing to increase within the first two minutes, while skin conductance rose only later, indicating a prolonged autonomic response. As the drug's effects waned, feelings of pleasantness and bliss emerged. Combining simple physiological measures with moment-by-moment self-reports offers a way to objectively characterize psychedelic-induced emotional states, which may aid future clinical biomarker research.

Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine.

Apollo (University of Cambridge) December 30, 2025 Evan Lewis-Healey, Carla Pallavicini, Federico Cavanna et al.

A dose of the fast-acting psychedelic drug DMT rapidly reorganizes both conscious experience and brain activity. In a blinded, counterbalanced study, 19 participants received either 20 mg or 40 mg of freebase DMT. The higher dose caused more extreme visual hallucinations and emotionally intense experiences. Electroencephalography showed that changes in alpha brainwave power and a measure of signal irregularity (permutation entropy) were most strongly linked to moment-by-moment changes in subjective experience. Surprisingly, a measure of neural signal complexity (Lempel-Ziv complexity), previously thought to be a robust marker of psychedelic states, showed the weakest link to experience. This suggests the connection between brain complexity and conscious experience during psychedelic states is less straightforward than previously assumed.